Old Web
English
Sign In
Acemap
>
authorDetail
>
Valkal Bhatt
Valkal Bhatt
Incyte
Medicine
steroid refractory
Internal medicine
Ruxolitinib
Pharmacology
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Patient-Reported Outcomes (PROs) Among Patients With Steroid-Refractory or -Dependent Chronic Graft-vs-Host Disease (cGVHD) Randomized to Ruxolitinib (RUX) vs Best Available Therapy (BAT)
2021
Blood
Stephanie J. Lee
Franco Locatelli
Francis Ayuk
Tsila Zuckerman
Kentaro Fukushima
Juan Carlos Vallejo Llamas
Joseph Pidala
Nada Hamad
Ivan S. Moiseev
Francesca Bonifazi
Shashikant Apte
Robert Zeiser
Valkal Bhatt
Maanasa Gowda
Jackie Han
Tommaso Stefanelli
Mike Zuurman
Takanori Teshima
Show All
Source
Cite
Save
Citations (0)
Safety Analysis of Patients Who Received Ruxolitinib for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease in an Expanded Access Program
2020
Blood
Parameswaran Hari
Haris Ali
Yi-Bin Chen
Salman Fazal
Tara K. Gregory
Sarah Anand
Ahmad Naim
Dilan Paranagama
Valkal Bhatt
Amy Blithe
John F. DiPersio
Show All
Source
Cite
Save
Citations (0)
Case study—methotrexate toxicity, treatment, and measurement
2020
Valkal Bhatt
Michael Scordo
Dean C. Carlow
Show All
Source
Cite
Save
Citations (0)
1